These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31006292)

  • 1. Ultrasonographic vascularity assessment for predicting future severe hemorrhage in retained products of conception after second-trimester abortion.
    Akiba N; Iriyama T; Nakayama T; Seyama T; Sayama S; Kumasawa K; Komatsu A; Yabe S; Nagamatsu T; Osuga Y; Fujii T
    J Matern Fetal Neonatal Med; 2021 Feb; 34(4):562-568. PubMed ID: 31006292
    [No Abstract]   [Full Text] [Related]  

  • 2. The RPOC long axis is a simple indicator for predicting the need of invasive strategies for secondary postpartum hemorrhage in either post-abortion or post-partum women: a retrospective case control study.
    Kobayashi M; Nakagawa S; Kawanishi Y; Masuda T; Maenaka T; Toda A; Miyake T; Hiramatsu K; Miyoshi A; Mimura K; Kimura T; Endo M; Kimura T
    BMC Pregnancy Childbirth; 2021 Sep; 21(1):653. PubMed ID: 34560846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sonographic Findings of Vascular Signals for Retained Products of Conception in Women Following First-Trimester Termination of Pregnancy.
    Lin F; Chen Z; Tao H; Ren X; Ma P; Lash GE; Shuai H; Li P
    J Obstet Gynaecol Can; 2024 Mar; 46(3):102266. PubMed ID: 37940040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of pregnancy-related enhanced myometrial vascularity following miscarriage.
    Grewal K; Al-Memar M; Fourie H; Stalder C; Timmerman D; Bourne T
    Ultrasound Obstet Gynecol; 2020 May; 55(5):676-682. PubMed ID: 31503383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Reproductive Outcomes following Retained Products of Conception after Vaginal Delivery versus First-Trimester Abortion.
    Melcer Y; Smorgick N; Schneider D; Pansky M; Halperin R; Ben-Ami I
    Gynecol Obstet Invest; 2015; 80(3):206-10. PubMed ID: 26088169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors of retained products of conception after miscarriage or termination with gemeprost in the second trimester of pregnancy: a retrospective case-controlled study in Japanese population.
    Noguchi T; Shiro M; Nanjo S; Mizoguchi M; Ota N; Mabuchi Y; Yagi S; Minami S; Ino K
    J Obstet Gynaecol; 2022 Apr; 42(3):501-504. PubMed ID: 34162287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expectant management of retained products of conception following abortion: A retrospective cohort study.
    Wada Y; Takahashi H; Suzuki H; Ohashi M; Ogoyama M; Nagayama S; Baba Y; Usui R; Suzuki T; Ohkuchi A; Fujiwara H
    Eur J Obstet Gynecol Reprod Biol; 2021 May; 260():1-5. PubMed ID: 33689917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Prediction of Retained Products of Conception: Combining Obstetric History and Ultrasound for Improved Accuracy in Severe Postpartum Hemorrhage.
    Kurakazu M; Kurakazu M; Kiyoshima C; Shigekawa K; Hirakawa T; Yoshikawa K; Ito T; Urushiyama D; Miyata K; Yotsumoto F
    Cureus; 2024 Feb; 16(2):e53651. PubMed ID: 38449994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and imaging predictors of management in retained products of conception.
    Kamaya A; Krishnarao PM; Nayak N; Jeffrey RB; Maturen KE
    Abdom Radiol (NY); 2016 Dec; 41(12):2429-2434. PubMed ID: 27853850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and ultrasonographic characteristics of pregnancy-related enhanced myometrial vascularity: prospective cohort study.
    Xholli A; Scovazzi U; Londero AP; Paudice M; Vacca I; Schiaffino MG; Kratochwila C; Cavalli E; Perugi I; Cagnacci A;
    Ultrasound Obstet Gynecol; 2024 May; 63(5):672-682. PubMed ID: 37984401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of using vaginal misoprostol for treatment of retained products of conception after first trimester miscarriage: a retrospective cohort study.
    Stewart KT; Lee JS; Pan K; Albert AY; Fisher S
    Eur J Contracept Reprod Health Care; 2020 Dec; 25(6):474-479. PubMed ID: 32869658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retained products of conception: spectrum of color Doppler findings.
    Kamaya A; Petrovitch I; Chen B; Frederick CE; Jeffrey RB
    J Ultrasound Med; 2009 Aug; 28(8):1031-41. PubMed ID: 19643786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uterine Artery Embolization for Retained Products of Conception with Marked Vascularity: A Safe and Efficient First-Line Treatment.
    Bazeries P; Paisant-Thouveny F; Yahya S; Bouvier A; Nedelcu C; Boussion F; Sentilhes L; Willoteaux S; Aubé C
    Cardiovasc Intervent Radiol; 2017 Apr; 40(4):520-529. PubMed ID: 28004170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic criteria for retained products of conception-A scoping review.
    Hamel CC; van Wessel S; Carnegy A; Coppus SFPJ; Snijders MPML; Clark J; Emanuel MH
    Acta Obstet Gynecol Scand; 2021 Dec; 100(12):2135-2143. PubMed ID: 34244998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasonographic technique to differentiate enhanced myometrial vascularity/arteriovenous malformation from retained products of conception.
    Thakur M; Strug MR; De Paredes JG; Rambhatla A; Munoz MIC
    J Ultrasound; 2022 Jun; 25(2):379-386. PubMed ID: 33651329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expectant therapy versus curettage for retained products of conception after second trimester termination of pregnancy: analysis of outcomes and complications].
    Zeng WJ; An SL; Huang H; Huang QT; Li FF; Wang HZ; Cai DC; Gao YF
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 May; 37(5):569-574. PubMed ID: 28539276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound features help identify patients who can undergo noninvasive management for suspected retained products of conception: a single institutional experience.
    Vyas S; Choi HH; Whetstone S; Jha P; Poder L; Shum DJ
    Abdom Radiol (NY); 2021 Jun; 46(6):2729-2739. PubMed ID: 33459841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of clinical and ultrasound findings in the diagnosis of retained products of conception.
    Abbasi S; Jamal A; Eslamian L; Marsousi V
    Ultrasound Obstet Gynecol; 2008 Oct; 32(5):704-7. PubMed ID: 18792059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and therapeutic decision-making with transvaginal sonography for first trimester spontaneous abortion, clinically thought to be incomplete or complete.
    Cetin A; Cetin M
    Contraception; 1998 Jun; 57(6):393-7. PubMed ID: 9693399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical management of retained products of conception: A prospective observational study.
    Schulte RL; Fox R; Anderson J; Young N; Davis L; Saxton V; Mooney SS
    Eur J Obstet Gynecol Reprod Biol; 2023 Jun; 285():153-158. PubMed ID: 37120911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.